Related Experiment Videos
The current status of tissue engineering as potential therapy
1Department of Surgery, Harvard Medical School, Boston, MA, USA.
Seminars in Pediatric Surgery
|August 26, 1999
Summary
Tissue engineering offers a novel solution for organ scarcity by creating biological substitutes. This approach uses cells on biodegradable scaffolds to develop functional living tissues, addressing end-stage organ disease and tissue loss.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Cell Biology
Background:
- End-stage organ disease and tissue loss present significant medical challenges.
- Organ transplantation is effective but limited by severe donor organ scarcity, particularly in pediatric cases.
- This scarcity drives research into alternative therapies like cell transplantation.
Purpose of the Study:
- To review the progress and current status of tissue engineering for treating end-stage organ disease and tissue loss.
- To highlight tissue engineering as a potential therapeutic strategy to overcome donor organ limitations.
Main Methods:
- Fabrication of functional living tissues using cells seeded on highly porous synthetic biodegradable polymer scaffolds.
- Application of tissue engineering principles over the past decade.
- Development of biological substitutes to replace lost tissue function.
Main Results:
- Successful fabrication of a wide variety of engineered tissues, including structural and visceral organs.
- Demonstrated progress in tissue engineering techniques and applications.
- Established tissue engineering as a viable field for developing organ replacements.
Conclusions:
- Tissue engineering represents a promising approach to address the critical shortage of donor organs.
- Engineered tissues can serve as biological substitutes for damaged or lost tissues and organs.
- Continued advancements in tissue engineering hold significant potential for treating end-stage organ disease.